ClinicalTrials.Veeva

Menu

Evaluation of Apelin-13 and Apelin-36 in Women With Recurrent Pregnancy Loss

A

Ain Shams University

Status

Completed

Conditions

Recurrent Pregnancy Loss

Treatments

Diagnostic Test: Apelin-13, Apelin-36

Study type

Observational

Funder types

Other

Identifiers

NCT05205044
MS 672/2021

Details and patient eligibility

About

Lower Apelin levels are associated with hypertensive disorders with pregnancy, yet no studies investigated its levels in recurrent pregnancy loss

Enrollment

88 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pregnant women in first trimester
  • negative antiphospholipid markers
  • normal karyotype

Exclusion criteria

  • multiple pregnancy
  • fetal malformations
  • maternal diseases
  • smoking or alcohol use
  • history of or risk factors for preterm labor

Trial design

88 participants in 2 patient groups

Recurrent pregnancy loss
Treatment:
Diagnostic Test: Apelin-13, Apelin-36
Healthy
Treatment:
Diagnostic Test: Apelin-13, Apelin-36

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems